BioSpace News Archive

Drug Development

Cynata Reports Positive Six-Month Data from Cohort A in Phase 1 Trial of CYP-001 in GvHD

Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX: CYP) is pleased to announce positive safety and sustained overall survival rates from a six month follow-up assessment of patients enrolled in Cohort A of its Phase 1 clinical trial of CYP-001.

June 12, 2018
·
1 min read
FYidoctors launches its new online store!

FYidoctors is proud to announce the launch of its e-commerce platform: shop.fyidoctors.com.

June 12, 2018
·
2 min read
Biotech Bay

Talis Biomedical Corporation awarded $5.6M by NIH

To fund development of clinically impactful Point-of-Care diagnostics for Antimicrobial-Resistant Bacteria

June 12, 2018
·
2 min read
BioMidwest

Forbes Names BrightStar Care One of the Best Franchises in America

National In-Home Care Agency Ranks amongst Industry Elite on Annual List

June 12, 2018
·
3 min read
Policy

PCMA Statement on HELP Committee Hearing on President’s Blueprint to Lower Drug Prices

The Pharmaceutical Care Management Association (PCMA) released the following statement on the Health, Education, Labor and Pensions Committee hearing, “The Cost of Prescription Drugs: Examining the President’s Blueprint ‘American Patients First’ to Lower Drug Prices:"

June 12, 2018
·
2 min read
Business

Petrichor Names Biopharmaceutical Industry Veteran Peter Greenleaf to Advisory Board

Petrichor Healthcare Capital Management announced the appointment of Peter Greenleaf to its Advisory Board.

June 12, 2018
·
3 min read
Deals

Crux Quality Solutions to Acquire Remote Dosimetry Services, LLC

Acquisition will strengthen company’s remote dosimetry lines with its integration into FlowBoardTM technology

June 12, 2018
·
2 min read
Pharm Country

US Dermatologists Report Significant Growth of Next-Generation Psoriasis Biologics--Novartis’ Cosentyx, Eli Lilly’s Taltz, and Janssen’s Tremfya

Growth of the IL-17 inhibitors and Tremfya has been at the expense of the established TNF inhibitors and Janssen’s own Stelara.

June 12, 2018
·
4 min read
Business

The American College of Veterinary Internal Medicine and VetBloom Enter into Unique Partnership

The American College of Veterinary Internal Medicine (ACVIM) has entered into a partnership with VetBloom

June 12, 2018
·
3 min read
CHUM Develops Distinctive Immunotherapy Program - Treating Cancer with the Patient’s Own Immune Cells

CHUM (Centre hospitalier de l’Université de Montréal) and CRCHUM (its research centre) are now working on a pioneering cancer immunotherapy that employs immune cell infusion. This ground-breaking, personalized approach treats patients using cells taken from their own tumours.

June 12, 2018
·
4 min read